$UTHR as a result of the Court’s decision, United Therapeutics believes that it is entitled to an order instructing the FDA to withdraw approval of $LQDA's NDA for Yutrepia.
It also intends to seek monetary damages for past infringement, which could include a royalty on past sales of Yutrepia.